Point72 Asia (Singapore) Pte. Ltd. Aclaris Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 45,659 shares of ACRS stock, worth $71,228. This represents 0.02% of its overall portfolio holdings.
Number of Shares
45,659
Previous 48,187
5.25%
Holding current value
$71,228
Previous $120 Million
41.54%
% of portfolio
0.02%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ACRS
# of Institutions
112Shares Held
92.9MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$22.2 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$15 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$13.9 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$7.87 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$7.75 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $104M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...